Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplify: Norethindrone Acetate TDS for Contraception
NCT01140217Phase 3Completed
- Sponsor
- Watson Pharmaceuticals
- Start
- May 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of norethisterone acetate in pregnancy, sponsored by Watson Pharmaceuticals. Primary endpoint: Pregnancy Rate at 1 year. Started May 2010; status: completed.
02
Drugs
norethisterone acetate
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT01140217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01140217.